Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients
Thomas Jefferson University
Thomas Jefferson University
Revolution Medicines, Inc.
Erasca, Inc.
Syndax Pharmaceuticals
Syndax Pharmaceuticals
H. Lee Moffitt Cancer Center and Research Institute